MedTrace Logo

Clinical Evaluation of Fortilink® TETRAfuse® Interbody Fusion Device in Subjects With Degenerative Disc Disease

NCT03761563 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2024-03-15

No results posted yet for this study

Summary

This is a prospective, multi-center, non-randomized post-market evaluation designed to collect and evaluate data on the safety and performance of the Fortilink IBF System with TETRAfuse 3D Technology.

Conditions

  • Degenerative Disc Disease

Interventions

DEVICE

Fortilink IBF System with TETRAfuse Technology

Cervical and lumbar fusion

Sponsors & Collaborators

  • Xtant Medical

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-13
Primary Completion
2023-06-30
Completion
2023-12-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03761563 on ClinicalTrials.gov